期刊文献+

白头翁皂苷D与不同血浆蛋白的结合率测定 被引量:5

Determination of Plasma Protein Binding Rate of Pulsatilla Saponin D in Several Species
原文传递
导出
摘要 目的:研究白头翁皂苷D与不同血浆蛋白的结合率。方法:采用HPLC与平衡透析法相结合的方法测定白头翁皂苷D与牛血清、人血浆及大鼠血浆中蛋白的结合率,COSMOSIL 5C18-MS-Ⅱ色谱柱(4.6 mm×250 mm,5μm),流动相甲醇-水-甲酸(80∶20∶0.02),检测波长203 nm。结果:白头翁皂苷D质量浓度为0.06,0.11,0.25 g·L-1时与牛血清白蛋白的结合率分别为(78.45±0.89)%,(77.61±1.14)%,(77.16±0.29)%,与人血浆蛋白的结合率分别为(68.91±0.54)%,(67.68±0.87)%,(67.88±0.71)%,与大鼠血浆蛋白的结合率分别为(78.15±0.76)%,(78.61±0.97)%,(78.24±0.93)%。结论:建立的白头翁皂苷D蛋白结合率测定方法简便、稳定、可靠。白头翁皂苷D是一种中等程度的蛋白结合药物,结合率不具有质量浓度依赖性。 Objective:To investigate different plasma protein binding rates of pulsatilla saponin D.Method:HPLC and equilibrium dialysis method were adopted to determine plasma protein binding rates of pulsatilla saponin D in bovine serum,human and rat plasma,COSMOSIL 5C18-MS-Ⅱ column (4.6 mm × 250 mm,5 μm) was employed with mobile phase of methanol-water-formic acid (80∶ 20∶ 0.02) and detection wavelength at 203 nm.Result:Plasma protein binding rates of pulsatilla saponin D at three various concentrations (0.06,0.11,0.25 g·L-1) were (78.45±0.89)%,(77.61±1.14)%,(77.16±0.29)% in bovine serum albumin,they were (68.91±0.54)%,(67.68±0.87)%,(67.88±0.71)% in human plasma and (78.15 ±0.76)%,(78.61 ±0.97)%,(78.24 ±0.93)% in rat plasma,respectively.Conclusion:This method for determining plasma protein binding rates of pulsatilla saponin D was simple,stable and reliable.Pulsatilla saponin D was a drug with moderate plasma protein binding rate,which did not have concentration-dependent manner.
出处 《中国实验方剂学杂志》 CAS 北大核心 2014年第8期114-117,共4页 Chinese Journal of Experimental Traditional Medical Formulae
基金 国家"重大新药创制"科技重大专项(2011ZX11102-001-19) 江西省自然科学基金项目(20114BAB215045) 江西省优势科技创新团队计划项目(2010DQB01700) 江西省教育厅产学研合作项目(GJJ11006)
关键词 白头翁皂苷D 蛋白结合率 高效液相色谱法 平衡透析法 pulsatilla saponin D protein binding rate HPLC equilibrium dialysis method
  • 相关文献

参考文献6

二级参考文献15

  • 1萧参,陈坚行.生物药剂分析方法的认证[J].中国药学杂志,1993,28(7):425-427. 被引量:20
  • 2WANG Hui, YE Guan, MA Chun-hui, et al. Iden- tication and determination of four metabolites of mangiferin in rat urine[J]. 3 Pharm Biomed Anal, 2007, 45(5): 793-798.
  • 3LAI Ling, LIN Lie-chwen, LIN Jer-huei, et al. Pharmacokinetic study of free mangiferin in rats by microdialysis coupled with microbore high- performance liquid chromatography and tandem mass spectrometry[J]. J Chromatogr A, 2003, 987(1- 2): 367-374.
  • 4PRABHU S, NARAYAN S, DEVI C S S. Mechanism of protective action of mangiferin on suppression of in ammatory response and lysosomaI instability in rat model of myocardial infarction[J]. Phytother Res, 2009, 23(6): 756-760.
  • 5MIURA T, ICHIKI H, HASHIMOTO I, et al. Antidiabetic activity of a xanthone compound, mangiferin[J]. Phytomedicine, 2001, 8(2): 85-87.
  • 6MURUGANANDAN S, SRINIVASAN K, GUPTA S, et ah Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats[J]. J Ethnopharmacol, 2005, 97(3): 497-501.
  • 7MIURA T, ICHIKI H, IWAMOTO N, et al. Antidia- betic activity of the rhizoma of anemarrhena aspho- deloides and active components, mangiferin and its glucoside[J]. Biol Pharm Bull, 2001, 24(9): 1009- 1 011.
  • 8LIN Hui, LAN Jing-feng, GUAN Min, et al. Spectroscopic investigation of interaction between mangiferin and bovine serum albumin[J]. Spec- trochimica Acta Part A, 2009, 73(5): 936-941.
  • 9YuN Yuan-yuan, CHEN Xing-guo, QIN Jin, et al. Characterization of the mangiferin-human serum albumin complex by spectroscopic and molecular modeling approaches[J]. J Pharm Biomed Anal, 2009, 49(3): 753-759.
  • 10TAYLOR S, HARKER A. Modication of the ultral- tration technique to overcome solubility and non- specific binding challenges associated with the mea- surement of plasma protein binding of corticos- teroids[J]. J Pharm Biomed Anal, 2006, 41(1): 299- 303.

共引文献17

同被引文献41

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部